Curative Cuts $600K Salesforce Deal After Building In‑House CRM
Curative’s founder Fred Turner announced the company terminated a $600,000‑per‑year Salesforce contract after delivering a home‑grown CRM in just two months. The move is part of an 80% reduction in SaaS spend this year, with the firm shifting budget to AI tools like Anthropic.
Why It Matters
The Curative case underscores a shift toward AI‑native, custom‑built platforms as a cost‑containment strategy. For SaaS vendors, especially those serving regulated verticals, the risk is heightened churn if customers can replicate core functionality with AI‑assisted development. For operators, the story validates the business case for reallocating spend from high‑margin SaaS licenses to AI tooling that can drive operational efficiency and new revenue streams.
If the trend accelerates, we could see a re‑segmentation of the SaaS market: legacy, high‑touch platforms may lose mid‑market customers to leaner, AI‑powered stacks, while niche vertical SaaS providers that embed AI deeply into their product may capture the upside.
Key Points
- Curative ended a $600,000‑per‑year Salesforce contract after building an in‑house CRM in two months.
- The company aims to cut roughly 80% of its SaaS spend in 2024.
- Anthropic spend grew from tens of thousands to millions of dollars per month, a 6‑fold monthly increase.
- AI agent "Gwen" reduced contract‑negotiation cost from $1,500‑$2,000 to about $70 per deal.
- Salesforce CEO Marc Benioff defended demand, citing Anthropic as a customer.
Analysis
Curative’s aggressive SaaS pruning reflects a broader inflection point where AI‑generated code is no longer a novelty but a competitive lever. The rapid development of a functional CRM in two months suggests that AI coding agents have crossed a threshold of reliability for core business workflows. This lowers the barrier for non‑tech founders to replace entrenched platforms, eroding the moat that SaaS giants have traditionally relied on—network effects and deep integration.
Historically, SaaS churn has been driven by price, feature gaps, or poor integration. Today, the catalyst is the ability to internalize functionality at a lower total cost of ownership, especially when AI can automate maintenance and iteration. Vendors that can embed AI into their own offerings—providing AI‑assisted customization rather than a static product—may retain relevance. Conversely, pure subscription models without a clear AI augmentation path risk becoming commoditized.
For investors, the Curative story signals a need to reassess valuation multiples for SaaS companies that lack AI‑native capabilities. Companies that can demonstrate AI‑driven cost efficiencies or that have built AI into their product roadmap may command premium multiples, while those reliant on legacy stacks could see valuation compression. The next wave of M&A may focus on acquiring AI talent and platforms that enable rapid, low‑code development, reshaping the competitive landscape of enterprise software.